593 Measuring Quality in Psoriasis: Early Experience With the MIPS 410 Quality Measure – Psoriasis: Clinical Response to Oral Systemic or Biologic Medications

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.669
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment Persistence in Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Biologic Therapies in HIV-infected Patients With Psoriasis: An Italian Experience

Acta Dermato-Venereologica
DermatologyMedicine
2017English

Psoriasis: Epidemiology, Clinical Features, and Quality of Life

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Experience With the Systemic Treatment of Severe Forms of Psoriasis

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2012English

Inflammatory Marker Alteration in Response to Systemic Therapies in Psoriasis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

Correction To: Psoriasis in Systemic Lupus Erythematosus: A Single-Center Experience

Clinical Rheumatology
MedicineRheumatology
2018English

Psoriasis, a Systemic Disease?

Turk Dermatoloji Dergisi
Dermatology
2012English

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis

Psoriasis Forum
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy